Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. senior Avg
|
New words:
AB, absolute, ADT, afflicted, afformentioned, Antegene, argue, ASP, ATM, Bio, bolster, California, Canadian, characteristic, cis, cleavage, CNS, collusion, combat, combo, commented, consecutive, constitutionality, cut, cyclophosphamide, dark, DBH, diffuse, disintegrin, DLBCL, Dohme, drew, driven, economy, effector, eighty, Eucure, evacuate, evergreen, Excellence, faulty, floating, FTI, GlaxoSmithKlein, grey, guarantor, hematological, Hodgkin, Horizon, HPV, hydroxydaunorubicin, ID, impermissible, impermissibly, inaccessible, Inferior, inoperable, IO, Johnson, Keytruda, leaflet, Leerink, leisure, linked, lymphoma, men, metalloproteinase, mistake, molcule, multitude, naive, Nanjing, neighboring, NHL, NSCLC, oncovin, override, overseen, paradigm, periphery, pioneering, plot, poorly, postponed, prednisone, PwC, Qilu, reclassified, Reg, Regeneron, relocate, repetition, revamp, rituximab, score, SD, Sharp, soft, software, soluble, SOX, Stingthera, subclaim, subscribe, subscribed, successor, supplementary, SVB, sweeping, Swimmer, TPS, Ukraine, und, underwent, unpatented, unsatisfactory, untreated, vaccinate, variously, Venture, Vermont, WAC
Removed:
accredited, biology, capacity, commit, comparison, concurrent, convenient, Dawson, deteriorate, EGC, ending, feedback, filer, furlough, governed, hire, implicated, indirect, interaction, irrevocably, manager, mandate, path, plc, presidential, proceed, redeemable, reproduce, reversed, revised, rotation, sampling, SBP, specificity, Sperovie, strain, unaudited
Filing tables
Filing exhibits
Related press release
Associated FSTX transcripts
FSTX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (No. 333-215122, No. 333-234436, No. 333-254884 and No. 333-258783) on Form S-3 and Registration Statements (No. 333-212047, No. 333-226508, No. 333-252396, No. 333-251033, No. 333-243754 and No. 333-263170) on Form S-8 of F-star Therapeutics, Inc. and subsidiaries of our report dated March 15, 2022, relating to the consolidated financial statements of F-star Therapeutics, Inc. and subsidiaries, appearing in this Annual Report on Form 10-K of F-star Therapeutics, Inc. for the year ended December 31, 2021.
/s/ RSM US LLP
Boston, Massachusetts
March 15, 2022